Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.09.24 | J&J Announces Promising Phase 1b/2 Data For Amivantamab Combination In Metastatic Colorectal Cancer | 1.243 | AFX News | NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a Johnson & Johnson (JNJ) company, announced new data from the Phase 1b/2 OrigAMI-1 study, which showed amivantamab combined with chemotherapy... ► Artikel lesen | |
14.09.24 | DIRECTV Reaches Agreement To Restore Disney Networks And Streaming Services | 1.072 | AFX News | BURBANK (dpa-AFX) - DIRECTV and The Walt Disney Company have reached an agreement in principle for the distribution of Disney's linear networks and direct-to-consumer services, following a roughly... ► Artikel lesen | |
14.09.24 | Pfizer: Phase 2 Study Of Ponsegromab In Cancer Cachexia Meets Primary Endpoint | 1.466 | AFX News | NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said Saturday that its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (GDF-15), met its primary... ► Artikel lesen | |
14.09.24 | Pfizer's BRAFTOVI + MEKTOVI Delivers Long-Term Benefits In BRAF V600E-Mutant NSCLC | 1.134 | AFX News | NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI (encorafenib)... ► Artikel lesen | |
14.09.24 | J&J: RYBREVANT + Chemotherapy Shows Strong Benefits And Improved Survival In Phase 3 NSCLC Trial | 851 | AFX News | NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced that updated results from the Phase 3 MARIPOSA-2 study showed that combining RYBREVANT (amivantamab-vmjw) with chemotherapy provided... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 400 |
EVOTEC | 221 |
TESLA | 208 |
RHEINMETALL | 200 |
NOVO NORDISK | 181 |
BYD | 164 |
BAYER | 125 |
RENK GROUP | 121 |
DEUTZ | 106 |
DEUTSCHE BANK | 99 |
STEYR MOTORS | 92 |
PLUG POWER | 85 |
TUI | 85 |
ALMONTY | 83 |
SIEMENS ENERGY | 81 |
BASF | 78 |
VOLKSWAGEN | 78 |
NEL | 73 |
AMAZON | 71 |
APPLE | 71 |
THYSSENKRUPP | 70 |
XIAOMI | 69 |
MERCEDES-BENZ | 67 |
COMMERZBANK | 63 |
LITHIUM ENERGI EXPLORATION | 63 |